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Abstract.  Acute exacerbation of systemic lupus erythematosus in pregnancy complicated by severe preeclampsia was 
difficult to diagnose and treat. This is the case of Mrs Y, 26 years old in 24 weeks gestational age with severe 
preeclampsia with active exacerbation of systemic lupus erythematosus. She had suffered from systemic lupus 
eryhtematosus for three years before she got pregnant. When she came the blood pressure was 180/110 mmHg, protein 
urine +3. There was complaint of stiffness on muscle joints, facial flares, general weakness, and photosensitivity. She 
was hospitalized for seven days before she was discharged. Her blood pressure was controlled and lupus symptoms were 
controlled by antihypertensive agents and antiinflamation agent metil prednisolone. A week later she came back to our 
hospital. Her blood pressure was 190/110 mmHg despite having antihypertensive. She also complaint of joints ache, 
general weakness, facial flares, and no fetal movement. On ultrasound examination there was intra uterine fetal death. 
From this case, we would like to assess the patophysiology of systemic lupus erythematosus and worsening symptoms of 
severe preeclampsia which cause the mortality and morbidity of mother and baby. 
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Introduction 
Systemic lupus erythematosus (SLE ) is a chronic,inflammatory multiorgan autoimmune 
disorder characterized by periods of remissions and relapse. The patophysiology of SLE is as 
follows.Antigen-antibody complexes are formed with a resulting secondary inflammatory 
response. The combination of the immune complexes and the secondary inflammatory response 
within the glomerulus leads to irreversible renal damage. Deposits also occur within the skin and 
other endothelial surface. During pregnancy, the most common clinical manifestations include 
arthralgia, fever, skin lesions and renal disease. SLE has effect on pregnancy while pregnancy 
also exacerbates the symptoms of SLE. There is increased rate of pregnancy loss in patients with 
SLE. The most important factor associated with SLE and pregnancy loss is the presence of 
antiphospholipid antibodies, other factors include renal disease, disease activity, and history of 
previous pregnancy loss. Antiphospholipid antibody, renal disease, and preeclampsia are risk 
factors for SLE. This paper is purposed to assess and review the patophysiology of systemic 
lupus erythematosus and its correlation with severe preeclampsia. 
 
Material and Methods 
This is the case of Mrs Y, 26 years old, had been suffering from systemic lupus 
erythematosus for 3 years while she got pregnant. She came to our hospital with chief complaint 
of malar rash, joint stiffness in her 24 weeks of pregnancy. She did antenatal care at obgyn 
every month. When she came, her blood pressure was 180/110 mmHg, protein urine +3. From 
ultrasound examination there was intra uterine singleton live fetus with severe oligohydramnion. 
We informed her and her family. They chose to conserve the pregnancy and denied the idea of 
pregnancy termination since it was her first pregnancy.  She was hospitalized for seven days 
before she was discharged. Her blood pressure was controlled and lupus symptoms were 
controlled by antihypertensive agents and antiinflamation agent metil prednisolone. A week later 
she came back to our hospital. Her blood pressure was 190/110 mmHg despite having 
antihypertensive. She also complaint of joints ache, general weakness, facial flares, and no fetal 
movement. On ultrasound examination there was intra uterine fetal death. Laboratory finding 
showed hemoglobin 12.3 g/dl, leukocyte 11.500 /UL, thrombocyte 71.000 /UL, increased level of 
ureum and creatinine, increased level of liver enzyme AST and ALT, the albumin level 1.9 g/dl. 
The peripheral blood smear showed anisocytosis, Burr cell (+) and leococytosis. Immunoserology 
showed Ig M and Ig G ACA was within normal limit. There was also disfunction in hemostasis 
which showed slightly longer coagulation test prothrombine time and activated partial 
prothrombine time as well as significantly evelated D-dimer 3594 ng/ml exceeding the normal 
value of 500 ng/ml. Regretfully we had to terminate her pregnancy by pregnancy induction. By 
inducing pregnancy, born baby boy, 870 grams, died maserated grade II.  
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Results and Discussion 
Systemic lupus erythematosus was chronic autoimmune disorder. Effect of pregnancy due 
to increased level of estrogen can create acute exacerbation of pregnancy. It was difficult to 
distinguish between acute exacerbation of SLE in early pregnancy and early onset of 
preeclampsia because both of them may have the manisfestation of hypertension, proteinuria, 
renal function deterioration, leucopenia, thrombocytopenia, as well as edema. Those 
characteristic presented in that patient in 24 weeks of gestational age. The strategy to 
distinguish between acute exacerbation and worsening of severe preeclampsia in patient with 
SLE who developed hypertension was the presence of hemolysis and elevated liver enzymes. It 
was shown in this patient that there was leukocytosis and the presence of Burr cell and 
anisocytosis in peripheral blood smear. It was highly suggestive that this patient suffer from 
severe preeclampsia exaggerated by HELLP syndrome. Patients with SLE have high risk of 
developing preeclampsia wih incidence of 15-32% with risk factors lupus nephritis, 
antiphospholipid syndrome (APS), and chronic hypertension. SLE can increase the risk of 
pregnancy loss due to hypertension, placental insufficiency, as well as may cause fetal and 
neonatal heart block. The patient in this study also suffered from acute exacerbation of SLE 
characterized by the presence of malar rash, joint ache, stomatitis, and fatigue syndrome. There 
was severe hypertension which could not be controlled by medication, proteinuria, renal function 
deterioration, hypoalbuminemia. There was also coagulation disorder with increased level of 
fibrinogen degradation products ex D-dimer which was suggestive of the disseminated 
intravascular coagulation (DIC).  
The patient in this study suffered from acute exacerbation of SLE which was compromised 
by many complications such as severe preeclampsia with uncontrolled hypertension, HELLP 
syndrome, and DIC. There was massive endothelial destruction with comsumptive coagulopathy 
which caused DIC. Because there was manifestation of severe preeclampsia, HELLP syndrome, 
the cause of intra uterine fetal death was because of severe placental insufficiency. The best 
management for this patient was termination of pregnancy. Severe endothelial destruction can 
deteriorate organs such as heart, vascular, renal, liver, and central nervous system. T would 
create bad prognosis for mother if pregnancy was prolonged. We still could not exclude the 
presence of APS although Ig M and Ig G ACA were within normal limit, because it should be 
added by Ig M and Ig G beta 2 glicoprotein examination which was quite expensive and 
unavailable in our center.  
 
Conclusions 
Patient with acute exacerbation of SLE complicated by severe preeclampsia, HELLP 
syndrome, was due to placental insufficiency. It created worse prognosis for the fetus.    
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